- Home
- MPW vs ICUI Comparison
MPW vs ICUI Comparison
Compare MPW & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPW
- ICUI
- Stock Information
- Founded
- MPW 2003
- ICUI 1984
- Country
- MPW United States
- ICUI United States
- Employees
- MPW N/A
- ICUI N/A
- Industry
- MPW Real Estate Investment Trusts
- ICUI Medical/Dental Instruments
- Sector
- MPW Real Estate
- ICUI Health Care
- Exchange
- MPW Nasdaq
- ICUI Nasdaq
- Market Cap
- MPW 3.0B
- ICUI 3.4B
- IPO Year
- MPW 2005
- ICUI 1992
- Fundamental
- Price
- MPW $4.58
- ICUI $134.86
- Analyst Decision
- MPW Hold
- ICUI Strong Buy
- Analyst Count
- MPW 6
- ICUI 5
- Target Price
- MPW $5.75
- ICUI $196.75
- AVG Volume (30 Days)
- MPW 8.8M
- ICUI 283.6K
- Earning Date
- MPW 05-01-2025
- ICUI 05-08-2025
- Dividend Yield
- MPW 7.00%
- ICUI N/A
- EPS Growth
- MPW N/A
- ICUI N/A
- EPS
- MPW N/A
- ICUI N/A
- Revenue
- MPW $994,715,000.00
- ICUI $2,420,093,000.00
- Revenue This Year
- MPW N/A
- ICUI N/A
- Revenue Next Year
- MPW $6.21
- ICUI N/A
- P/E Ratio
- MPW N/A
- ICUI N/A
- Revenue Growth
- MPW 23.40
- ICUI 7.22
- 52 Week Low
- MPW $3.51
- ICUI $101.44
- 52 Week High
- MPW $6.55
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- MPW 32.92
- ICUI 48.47
- Support Level
- MPW $4.44
- ICUI $127.91
- Resistance Level
- MPW $4.70
- ICUI $135.62
- Average True Range (ATR)
- MPW 0.15
- ICUI 4.35
- MACD
- MPW -0.03
- ICUI -0.26
- Stochastic Oscillator
- MPW 13.97
- ICUI 33.77
About MPW Medical Properties Trust Inc. common stock
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. The group's geographic areas are the United States, the United Kingdom, and All other countries.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.